# Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

> **NCT00355641** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 450 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Ropinirole Extended Release (XR)

## Key facts

- **NCT ID:** NCT00355641
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355641, "Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00355641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*